Global Blood Glucose Monitoring Systems Market Set for Strong Expansion, Reaching $24.67 Billion With 6.8% CAGR by 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the persuasion psychology market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Blood Glucose Monitoring Systems Market in 2030?
The blood glucose monitoring systems market size has experienced significant expansion in recent years. This market is set to grow from $17.66 billion in 2025 to $19 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.6%. Historically, this growth has been fueled by factors including the escalating global prevalence of diabetes, increased public consciousness of glucose self-monitoring, the early availability of invasive glucose meters and test strips, the broadening scope of home healthcare and outpatient diabetes treatment, and a heightened focus on glycemic regulation to diminish associated complications.
The blood glucose monitoring systems market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach a valuation of $24.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. The anticipated growth during this period stems from several factors, including an escalating demand for continuous and flash glucose monitoring systems, a greater embrace of wearable and implantable monitoring devices, an increased adoption of remote and connected solutions for diabetes management, the expanding presence of non-invasive glucose sensing technologies, and a broader application of monitoring systems across type 2, type 1, and gestational diabetes care. Key trends anticipated for the forecast timeframe involve the increasing uptake of continuous and real-time blood glucose monitoring solutions, a notable move towards minimally invasive and non-invasive glucose monitoring technologies, a rise in the utilization of portable, home-based, and self-monitoring glucose devices, the broader integration of blood glucose monitoring into preventive and chronic disease management, and a dedicated emphasis on improving accuracy, convenience, and patient autonomy within diabetes care.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17097&type=smp
What Drivers Are Influencing Production Trends In The Blood Glucose Monitoring Systems Market?
The increasing occurrence of diabetes among the population is anticipated to fuel the expansion of the blood glucose monitoring systems market in the future. This rise in the diabetic population’s prevalence stems from elements like inactive lifestyles, poor dietary habits, an aging demographic, and inherited predispositions. Blood glucose monitoring systems serve the purpose of tracking and regulating blood sugar levels, contributing to disease management and averting potential complications. As an illustration, in 2025, data from the International Diabetes Federation, a Belgium-based health organization, indicated that in 2024, approximately 589 million adults between 20-79 years old had diabetes. This figure is forecasted to climb to 853 million by 2050, with over 4 in 5 adults with diabetes living in low and middle income countries. A higher incidence of diabetes is linked to factors including being born abroad, inhabiting underserved regions, and possessing a disability. Consequently, the growing prevalence of the diabetic population will be a key driver for the blood glucose monitoring systems market.
Which Segment Groups Are Influencing The Blood Glucose Monitoring Systems Market?
The blood glucose monitoring systems market covered in this report is segmented –
1) By Type: Non-Invasive, Invasive
2) By Device Type: Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems
3) By Testing Site: Fingertip Testing, Alternate Site Testing
4) By Distribution Channel: Institutional Sales, Retail Sales
5) By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes
Subsegments:
1) By Non-Invasive: Optical Sensors, Ultrasound-Based Sensors, Bioimpedance-Based Sensors, Electromagnetic Sensors, Tear Or Saliva-Based Sensors
2) By Invasive: Continuous Glucose Monitoring (CGM) Systems, Self-Monitoring Blood Glucose (SMBG) Systems, Implantable Glucose Monitoring Devices, Flash Glucose Monitoring Systems
Which Trends Are Guiding The Evolution Of The Blood Glucose Monitoring Systems Market?
Leading companies within the glucose monitoring systems market are concentrating on developing innovative glucose monitoring solutions, such as advanced hybrid closed-loop systems and smartphone applications for immediate data access and management. Advanced hybrid closed-loop systems are defined as glucose monitoring devices that automate insulin delivery based on real-time glucose levels, enhancing blood sugar regulation for individuals with diabetes. For instance, in February 2024, DexCom Inc., a US-based continuous glucose monitoring systems manufacturing company, introduced Dexcom ONE+ in various European countries. Dexcom ONE+ incorporates the company’s best-in-class sensor technology and features designed to provide a user-friendly, highly effective continuous glucose monitoring (CGM) experience for people with type 1 or type 2 diabetes who use insulin. The system is composed of a water-resistant sensor, a transmitter that sends CGM readings, and a Dexcom One smartphone-compatible app. Dexcom ONE+ enables real-time monitoring of blood glucose by both the user and up to ten additional people, facilitating shared monitoring.
Who Are The Core Companies Influencing Trends In The Blood Glucose Monitoring Systems Market?
Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Medtronic plc, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc., Omron Healthcare Co Ltd, Trividia Health Inc.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Blood Glucose Monitoring Systems Market In The Coming Years?
North America was the largest region in the blood glucose monitoring systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Blood Glucose Monitoring Systems Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=17097&type=smp
Browse Through More Reports Similar to the Global Blood Glucose Monitoring Systems Market 2026, By The Business Research Company
Blood Glucose Meters Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
Continous Blood Glucose Monitoring Global Market Report 2026
Continuous Glucose Monitoring Devices Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
